153 related articles for article (PubMed ID: 26188675)
1. [Peritoneal tumor pathology - case no. 6: major histologic colloid response of colorectal peritoneal carcinomatosis after induction treatment].
Bibeau F
Ann Pathol; 2015 Aug; 35(4):347-50. PubMed ID: 26188675
[No Abstract] [Full Text] [Related]
2. Neoadjuvant FOLFOX chemotherapy in 34 consecutive patients with mucinous peritoneal carcinomatosis of appendiceal origin.
Sugarbaker PH; Bijelic L; Chang D; Yoo D
J Surg Oncol; 2010 Nov; 102(6):576-81. PubMed ID: 20737420
[TBL] [Abstract][Full Text] [Related]
3. [Peritoneal tumor pathology - case no. 1: pseudomyxoma peritonei].
Dartigues P
Ann Pathol; 2015 Aug; 35(4):311-20. PubMed ID: 26210688
[No Abstract] [Full Text] [Related]
4. Routine second-look after surgical treatment of colonic peritoneal carcinomatosis.
Delhorme JB; Triki E; Romain B; Meyer N; Rohr S; Brigand C
J Visc Surg; 2015 Jun; 152(3):149-54. PubMed ID: 25650364
[TBL] [Abstract][Full Text] [Related]
5. [Peritoneal tumor pathology - case no. 3 : peritoneal well-differentiated papillary mesothelioma].
Dartigues P
Ann Pathol; 2015 Aug; 35(4):327-37. PubMed ID: 26210689
[No Abstract] [Full Text] [Related]
6. Inguinal canal as an anatomic sanctuary site of relapse in peritoneal carcinomatosis previously treated with intraperitoneal chemotherapy.
Liberale G; Elias D; Sideris L; Lasser P; Malka D; Sabourin JC; Pocard M
J Surg Oncol; 2005 Jul; 91(1):73-6. PubMed ID: 15999360
[TBL] [Abstract][Full Text] [Related]
7. Mucinous histology of colon cancer predicts poor outcomes with FOLFOX regimen in metastatic colon cancer.
Maisano R; Azzarello D; Maisano M; Mafodda A; Bottari M; Egitto G; Nardi M
J Chemother; 2012 Aug; 24(4):212-6. PubMed ID: 23040685
[TBL] [Abstract][Full Text] [Related]
8. [A case report of advanced mucinous adenocarcinoma of the transverse colon with peritoneal dissemination effectively treated by multidisciplinary approach with a focus on FOLFOX4 therapy combined with panitumumab].
Asano T; Negita M; Uemura T; Takagi D; Hattori M; Kamiya I
Gan To Kagaku Ryoho; 2012 Jul; 39(7):1147-9. PubMed ID: 22790058
[TBL] [Abstract][Full Text] [Related]
9. [A case of multiple hepatic and peritoneal metastases from colon cancer responding to oral UFT+leucovorin chemotherapy].
Asai K; Fujita T; Nakamura Y; Tokuda E; Hiyoshi M; Aoki F; Sugizaki K; Masaki Y
Gan To Kagaku Ryoho; 2005 Nov; 32(12):1959-61. PubMed ID: 16282735
[TBL] [Abstract][Full Text] [Related]
10. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study.
Hompes D; D'Hoore A; Van Cutsem E; Fieuws S; Ceelen W; Peeters M; Van der Speeten K; Bertrand C; Legendre H; Kerger J
Ann Surg Oncol; 2012 Jul; 19(7):2186-94. PubMed ID: 22395983
[TBL] [Abstract][Full Text] [Related]
11. Indication for oophorectomy during cytoreduction for intraperitoneal metastatic spread of colorectal or appendiceal origin.
Evers DJ; Verwaal VJ
Br J Surg; 2011 Feb; 98(2):287-92. PubMed ID: 21046680
[TBL] [Abstract][Full Text] [Related]
12. Impact of preoperative chemotherapy on the histological response of patients with peritoneal metastases from colorectal cancer according to peritoneal regression grading score (PRGS) and TRG.
Taibi A; Lo Dico R; Kaci R; Naneix AL; Mathonnet M; Pocard M
Surg Oncol; 2020 Jun; 33():158-163. PubMed ID: 32561082
[TBL] [Abstract][Full Text] [Related]
13. [Cytostatic treatment of pseudomyxoma peritonei].
Schneider T; Lotze W
Zentralbl Gynakol; 1985; 107(24):1525-7. PubMed ID: 3004068
[TBL] [Abstract][Full Text] [Related]
14. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy.
Sugarbaker PH; Alderman R; Edwards G; Marquardt CE; Gushchin V; Esquivel J; Chang D
Ann Surg Oncol; 2006 May; 13(5):635-44. PubMed ID: 16523363
[TBL] [Abstract][Full Text] [Related]
15. [A case of advanced colon cancer with peritoneal dissemination effectively treated with modified FOLFOX6 chemotherapy].
Tanaka K; Hirai K; Ogawa H; Toya H; Totsuka O; Yoshinari D; Sunose Y; Takeyoshi I
Gan To Kagaku Ryoho; 2012 Jun; 39(6):993-5. PubMed ID: 22705700
[TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin-related acute myelogenous leukemia.
Carneiro BA; Kaminer L; Eldibany M; Sreekantaiah C; Kaul K; Locker GY
Oncologist; 2006 Mar; 11(3):261-2. PubMed ID: 16549810
[TBL] [Abstract][Full Text] [Related]
17. Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer.
Roviello F; Pinto E; Corso G; Pedrazzani C; Caruso S; Filippeschi M; Petrioli R; Marsili S; Mazzei MA; Marrelli D
J Surg Oncol; 2010 Nov; 102(6):663-70. PubMed ID: 20721959
[TBL] [Abstract][Full Text] [Related]
18. Bevacizumab doubles the early postoperative complication rate after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal origin.
Eveno C; Passot G; Goéré D; Soyer P; Gayat E; Glehen O; Elias D; Pocard M
Ann Surg Oncol; 2014 Jun; 21(6):1792-800. PubMed ID: 24337648
[TBL] [Abstract][Full Text] [Related]
19. [A case of advanced colon cancer successfully treated with combination therapy of cetuximab and oxaliplatin, leucovorin, and 5-fluorouracil].
Ojima E; Nakano T; Kanamoto A; Sasaki S
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1962-4. PubMed ID: 24393980
[TBL] [Abstract][Full Text] [Related]
20. The "alphabet soup" of peritoneal dissemination from appendiceal neoplasms and other malignancies.
Kane JM
Ann Surg Oncol; 2006 May; 13(5):597-9. PubMed ID: 16538404
[No Abstract] [Full Text] [Related]
[Next] [New Search]